New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness
Antibodies have proven their high value in antitumor therapy over the last two decades. They are currently being used as the first-choice to treat some of the most frequent metastatic cancers, like HER2+ breast cancers or colorectal cancers, currently treated with trastuzumab (Herceptin) and bevaciz...
Main Authors: | Isabel Corraliza-Gorjón, Beatriz Somovilla-Crespo, Silvia Santamaria, Jose A. Garcia-Sanz, Leonor Kremer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2017.01804/full |
Similar Items
-
Immune checkpoint-targeted antibodies: a room for dose and schedule optimization?
by: Christophe Maritaz, et al.
Published: (2022-01-01) -
Improving Biologics’ Effectiveness in Clinical Oncology: From the Combination of Two Monoclonal Antibodies to Oligoclonal Antibody Mixtures
by: Christel Larbouret, et al.
Published: (2021-09-01) -
Combination therapy of therapeutic antibody and vaccine or entecavir in HBV carrier mice
by: Ruoyao Qi, et al.
Published: (2023-05-01) -
Bispecific antibodies for viral immunotherapy
by: Elisabeth K. Nyakatura, et al.
Published: (2017-04-01) -
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses
by: Antonio Tapia-Galisteo, et al.
Published: (2024-12-01)